Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Haematococcus pluvialis astaxanthin solid beverage with function of maintaining health of cardiovascular system

A technology of Haematococcus pluvialis and solid beverage, which is applied in the directions of cardiovascular system diseases, plant raw materials, functions of food ingredients, etc. Eliminate free radicals between human cells and free radicals in cells, suitable for a wide range of people, and easy to take.

Inactive Publication Date: 2019-04-19
云南龙布瑞生物科技有限公司
View PDF5 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] At present, the products for the auxiliary treatment of cardiovascular diseases are generally medicines and health products. The raw materials used in medicines are chemical synthesis or microbial fermentation products, and the raw materials used in health products are mostly Chinese medicinal materials. effect, but these medicines or health care products have some toxic and side effects
With the development and utilization of astaxanthin, a series of astaxanthin-based capsules and tablet foods have also appeared on the market, but these foods containing astaxanthin are generally expensive and inconvenient to eat. Symptoms with insignificant effects

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0024] The Haematococcus pluvialis astaxanthin solid beverage for maintaining the health of the cardiovascular system described in Example 1 includes the following raw materials in mass percent: 5% astaxanthin, 35% mannan oligosaccharides, 30% wheat oligopeptides %, celery extract 29.5% and vitamin C 0.5%.

[0025] The Haematococcus pluvialis astaxanthin solid drink is 5% astaxanthin, 35% mannan oligosaccharides, 30% wheat oligopeptides, 29.5% celery extract and 0.5% vitamin C. Stir in a mixer for 20 minutes, Then the stirred and mixed mixture is sent to a boiling granulation tower for granulation. During granulation, the temperature is controlled at 30°C and the time is 20 minutes. After that, the granules obtained by granulation are cooled to obtain the finished product.

[0026] Among them: wheat oligopeptide is a mixture of various short peptides obtained by enzymatic degradation of wheat bone protein powder, which can be purchased directly in the market.

[0027]The mann...

Embodiment 2

[0031] The Haematococcus pluvialis astaxanthin solid beverage for maintaining the health of the cardiovascular system described in Example 2 includes the following raw materials in mass percent: 10% astaxanthin, 33% mannooligosaccharides, and 30% wheat oligopeptides %, celery extract 25%, vitamin C 0.8%, 1% auxiliary material and 0.2% flavoring agent.

[0032] The Haematococcus pluvialis astaxanthin solid drink is first prepared by adding 10% astaxanthin, 33% mannan oligosaccharides, 30% wheat oligopeptides, 25% celery extract, 0.8% vitamin C, 1% auxiliary materials Stir with 0.2% flavoring agent in the mixer for 20-30 minutes, and then send the stirred and mixed mixture into the fluidized granulation tower for granulation. During granulation, the temperature is controlled at 30-45 ° C, and the time is 20-30 minutes. , and then the finished product can be obtained after cooling the granulated granules

[0033] in:

[0034] The auxiliary materials include the following compon...

Embodiment 3

[0041] The Haematococcus pluvialis astaxanthin solid beverage for maintaining the health of the cardiovascular system described in Example 3 includes the following raw materials in mass percent: 15% astaxanthin, 35% mannooligosaccharides, 25.5% wheat oligopeptides %, celery extract 20%, vitamin C 1%, 3% auxiliary materials and 0.5% flavoring agent.

[0042] The Haematococcus pluvialis astaxanthin solid beverage is first prepared by adding 15% astaxanthin, 35% mannan oligosaccharides, 25.5% wheat oligopeptides, 20% celery extract and 1%, 3% vitamin C Stir with 0.5% flavoring agent in the mixer for 28 minutes, and then send the stirred and mixed mixture into the boiling granulation tower for granulation. During granulation, the temperature is controlled at 38 ° C, and the time is 30 minutes. After that, the granulation is obtained The finished product can be obtained after the pellets are cooled.

[0043] Wherein the auxiliary materials include the following components by mass:...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
pore sizeaaaaaaaaaa
pore sizeaaaaaaaaaa
quality scoreaaaaaaaaaa
Login to View More

Abstract

The invention discloses a haematococcus pluvialis astaxanthin solid beverage with a function of maintaining the health of a cardiovascular system. The haematococcus pluvialis astaxanthin solid beverage is prepared from, by mass, 5-15% of astaxanthin, 30-35% of manno-oligosaccharides, 20-30% of wheat oligopeptides, 20-30% of a celery extract and 0.5-1% of a vitamin C. The haematococcus pluvialis astaxanthin solid beverage with the function of maintaining the health of the cardiovascular system has the advantages that a traditional astaxanthin food is matched with a new resource food, after reasonable compatibility, a novel beverage food is obtained, taking is more convenient, simply the product is taken by being melted in water and can be taken for a long term, and after being taken, the novel beverage food not only can reduce the probability of hypertension, stroke and heart attack, enhance capillary blood flow, improve the quality of a blood antioxidant, and improve the vascular endothelial health, but also can assist in reducing blood fat and blood glucose; the ingredients are natural, have no toxic and side effects on the human body, and cannot generate side effects and leave chemical toxicants in vivo like drugs.

Description

technical field [0001] The invention belongs to the technical field of food production, and in particular relates to a Haematococcus pluvialis astaxanthin solid beverage for maintaining the health of the cardiovascular system. Background technique [0002] Cardiovascular and cerebrovascular diseases can be divided into cardiovascular diseases and cerebrovascular diseases. Cardiovascular diseases are mainly coronary heart disease, which is caused by atherosclerosis in the coronary arteries that supply blood to the myocardium, narrowing or occluding the arteries, and insufficient blood supply to the myocardium. Clinically, it can be divided into occult coronary heart disease, angina pectoris, myocardial infarction Infarction, myocardial fibrosis, and sudden cardiac death. Cerebrovascular disease is a group of diseases with cerebral hemorrhagic or ischemic damage as the main clinical manifestation caused by rupture of cerebral blood vessels or thrombosis on the basis of cerebr...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A23L2/395A23L33/105A23L33/125A23L33/18A23L33/10A61K38/01A61P9/00A61P37/04A61K31/122A61K31/715A61K36/23A61K31/375
CPCA23L2/395A23V2002/00A61K31/122A61K31/375A61K31/715A61K36/23A61K38/011A23L33/10A23L33/105A23L33/125A23L33/18A23V2200/30A23V2200/326A23V2200/3262A23V2200/328A23V2250/21A23V2250/211A23V2250/28A23V2250/55A23V2250/708A23V2300/10A23V2300/14A23V2200/14A23V2200/15A61K2300/00
Inventor 王维一杨祖刚翟运辉田晓艳周全勇
Owner 云南龙布瑞生物科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com